“dna” Archives

in
Entry Author Date Location
Foghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck 07/08/20 Boston
Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers 04/08/20 National
Vizgen Launches With $14M to Market New Subcellular Imaging Technique 01/30/20 Boston
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further 09/23/19 Boston
Challenging CRISPR, Trucode Raises $34M for New Gene-Editing System 09/10/19 San Francisco
Sequencing Firm Adaptive’s $300M IPO Comes With Pharma Ambitions 06/27/19 Seattle
Locana, Fueled With $55M, Looks to Develop Fixes for Faulty RNA 06/21/19 San Diego
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs 03/22/19 San Diego
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy 01/31/19 New York
LunaDNA Health Data Platform to Merge with Genetic Alliance Database 01/22/19 San Diego
Synthorx Gets $131M in Upsized IPO for Synthetic Biology Drugs 12/07/18 San Diego
Under Fire, He Jiankui Says He’s “Proud” to Help Make CRISPR’d Babies 11/28/18 National
U.S. Court Affirms Broad’s CRISPR Patent; No Word of Berkeley Appeal 09/10/18 Boston
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More 07/20/18 National
Helix Expands Real-World and Online Footprint with HumanCode Deal 06/26/18 San Francisco
Catalog Hauls In $9M to Make DNA-Based Data Storage Commercially Viable 06/26/18 Boston
Exact Sciences, Mayo Clinic Share Data on DNA-Based Liver Cancer Test 06/06/18 Wisconsin
“Wrong to Toast”: Broad’s Lander Sorry for Tribute to DNA Pioneer Watson 05/14/18 Boston
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M 05/14/18 Boston
Exact Sciences Beats Quarterly Forecasts, Sending Its Stock Price Up 04/26/18 Wisconsin
Nutrition-Focused GenoPalate Joins Crowd of DNA Test Kit Companies 04/05/18 Wisconsin
Helix Raises $200M to Build Its DNA “App Store” Beyond the Family Tree 03/01/18 San Francisco
Fresh Off $25M Raise, Generation Adds $100M For Next-Gen Gene Therapy 02/27/18 Boston
Andreessen Horowitz Backs Asimov’s Synthetic Biology CAD Software 12/19/17 Boston
15 For ’18: Key Clinical Data to Watch For Next Year (Part 2) 12/06/17 National
From UCSF, New Sequencer Reveals Cancer Blueprints, Cell By Cell 10/17/17 San Francisco
23andMe Raises $250M For Consumer Disease-Risk Tests, Drug R&D 09/12/17 San Francisco
San Antonio’s CellRight Sells to U.K. Medical Company Tissue Regenix 08/09/17 Texas
Homology Med Bags $83.5M More, Fueling Push For Gene Editing Twist 08/01/17 Boston
Page 1 of 4 next page »